Published October 2021 | Version v1
Journal article

The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis

  • 1. Department of Radiation Oncology, Seoul National University College of Medicine (Korea, Republic of)
  • 2. Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University, Boramae Medical Center (Korea, Republic of)
  • 3. Department of Radiation Oncology, Ewha Womans University College of Medicine (United States)
  • 4. Department of Internal Medicine, Seoul National University College of Medicine (Korea, Republic of)
  • 5. Department of Surgery, Seoul National University College of Medicine (Korea, Republic of)
  • 6. Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul (Korea, Republic of)

Description

Despite frequent use in the clinical setting, especially for patients with high-risk factors for relapse, the role of adjuvant treatment has not been clarified in nonhilar extrahepatic bile duct cancer (NH-EHBDC). The goal of this study is to identify the role of adjuvant chemoradiotherapy (CRT) in NH-EHBDC patients after radical surgery.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2021.05.012

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2021.05.012;
PII
S0360301621005423;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
111
Journal Issue
2
Journal Page Range
p. 395-404
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53124682
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BILIARY TRACT; COMBINED THERAPY; HEALTH HAZARDS; NEOPLASMS; PATIENTS; SURGERY
Descriptors DEC
DIGESTIVE SYSTEM; DISEASES; HAZARDS; MEDICINE; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.